Merestinib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Merestinib, covering 2021-02-26 to 2024-04-11. Get the full timeline:
Most recent: Clinical Trial Update: Merestinib In Non-Small Cell Lung Cancer And Solid Tumors [Phase 2]